ArticleCancer research2017

Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin-EGFR Pathway.

Meng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.